Treatment of hepatitis C in potential lung transplant candidates.

  title={Treatment of hepatitis C in potential lung transplant candidates.},
  author={Karen Elizabeth Doucette and Justin Weinkauf and Suzanne Sumner and Karen M Ens and Dale Lien},
  volume={83 12},
International guidelines list hepatitis C virus (HCV) as a contraindication to lung transplant (LTx). Since the development of these guidelines, the natural history of HCV after nonhepatic transplant has been clarified, and more effective antiviral therapy is available. In renal transplant candidates, HCV treatment before transplantation improves posttransplant outcome. There are no data regarding the safety and efficacy of HCV therapy in LTx candidates. We describe the outcomes of HCV… CONTINUE READING


Publications citing this paper.
Showing 1-4 of 4 extracted citations

Chronic hepatitis C treatment in a cystic fibrosis patient in the pulmonary pre-transplant stage.

Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva • 2010
View 9 Excerpts
Highly Influenced

Impact of donor and recipient hepatitis C status in lung transplantation

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation • 2016
View 1 Excerpt

Viral Hepatitis in Solid Organ Transplantation

J. Levitskya, K. Doucetteb
View 3 Excerpts

Viral hepatitis in solid organ transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons • 2009